Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders
2015年2月3日 - 9:24AM
ビジネスワイヤ(英語)
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of Medifast, Inc. (“Medifast” or the
“Company”) (NYSE:MED) concerning the improper compensation of the
Company’s executives.
Medifast’s key executive compensation increased drastically from
approximately $2.12 million in 2012 to approximately $12.11 million
in 2013. This is an especially significant increase given the fact
that key executive compensation was under $2 million for each year
from 2009 to 2011. While the key executive compensation has
increased dramatically, there has not been any significant increase
in the Company’s stock price.
If you are a Medifast stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, or telephone at (212) 699-1145, Melissa
Fortunato, Esq. by email at mfortunato@kmllp.com, or telephone at
(212) 699-1141, or toll free at (888) 529-4787, or by filling out
this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, whistleblower, antitrust and consumer litigation.
For additional information, please go to www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq.,
212-699-1145bwalker@kmllp.comorMelissa Fortunato, Esq.,
212-699-1141mfortunato@kmllp.com
Medifast (NYSE:MED)
過去 株価チャート
から 6 2024 まで 7 2024
Medifast (NYSE:MED)
過去 株価チャート
から 7 2023 まで 7 2024